azacitidine and Leukemia, Myelogenous, Aggressive Phase

azacitidine has been researched along with Leukemia, Myelogenous, Aggressive Phase in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badar, T; Borthakur, G; Cortes, JE; Daver, N; Jabbour, E; Kantarjian, HM; Newberry, KJ; Pemmaraju, N; Pierce, SR; Ravandi, F; Verstovsek, S	1
Beran, M; de Vos, D; Estey, E; Giralt, S; Kantarjian, HM; Keating, M; Kornblau, S; O'Brien, SM; Rios, MB; Talpaz, M	1
Arlin, Z; Bennett, JM; Dutcher, JP; Eudey, L; Kellermeyer, R; O'Connell, M; Oken, M; Paietta, E; Rowe, J; Wiernik, PH	1

Trials

2 trial(s) available for azacitidine and Leukemia, Myelogenous, Aggressive Phase

Article	Year
Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia. Leukemia, 1997, Volume: 11, Issue:10 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Blast Crisis; Decitabine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged	1997
Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group. Leukemia, 1992, Volume: 6, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Blast Crisis; Drug Evaluation; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Mitoxantrone; Remission Induction	1992

Article

Year

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia.

Leukemia, 1997, Volume: 11, Issue:10

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Blast Crisis; Decitabine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged

1997

Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.

Leukemia, 1992, Volume: 6, Issue:8

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Blast Crisis; Drug Evaluation; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Mitoxantrone; Remission Induction

1992

Other Studies

1 other study(ies) available for azacitidine and Leukemia, Myelogenous, Aggressive Phase

Article	Year
Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phase. Leukemia research, 2015, Volume: 39, Issue:9 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blast Crisis; Decitabine; Female; Humans; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Primary Myelofibrosis; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome	2015

Article

Year

Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phase.

Leukemia research, 2015, Volume: 39, Issue:9

Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Blast Crisis; Decitabine; Female; Humans; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Primary Myelofibrosis; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome

2015